Novocure Stock Forecast

Buy candidate since Aug 10, 2026

The NovoCure Limited stock price gained 5.61% on the last trading day (Monday, 10th Aug 2026), rising from $16.39 to $17.31. During the last trading day the stock fluctuated 8.11% from a day low at $16.27 to a day high of $17.59. The price has been going up and down for this period, and there has been a 1.64% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 105 thousand more shares were traded than the day before. In total, 999 thousand shares were bought and sold for approximately $17.30 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.01% during the next 3 months and, with a 90% probability hold a price between $11.66 and $18.08 at the end of this 3-month period.

NVCR Signals & Forecast

The NovoCure Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $15.98 and $16.10. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, July 31, 2026, and so far it has risen 16.64%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for NovoCure Limited stock

NovoCure Limited finds support from accumulated volume at $17.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.32 between high and low, or 8.11%. For the last week, the stock has had daily average volatility of 5.05%.

Our recommended stop-loss: $16.63 (-3.90%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (NVCR) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect NovoCure Limited to open at $17.06, and during the day (based on 14 day Average True Range), to move between $16.77 and $17.85, which gives a possible trading interval of +/-$1.07 (+/-6.40%) up or down from last closing price. If NovoCure Limited takes out the full calculated possible swing range there will be an estimated 6.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $17.16 (0.87%) than the resistance at $17.65 (1.96%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is NovoCure Limited stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.783 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $17.06 ( 1.46%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk